Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results
Rhea-AI Summary
Nature's Sunshine (Nasdaq: NATR) reported fourth quarter and full year 2025 results, with full year net sales of $480.1M (up 5.7%) and GAAP net income of $19.5M or $1.06 per diluted share. Adjusted EBITDA rose to $49.4M (+21.7%).
Q4 net sales were $123.8M (+4.7%), Q4 GAAP net income was $4.1M and cash was $93.9M with no debt. 2026 guidance: net sales $500–$515M; adjusted EBITDA $50–$54M.
Positive
- Adjusted EBITDA +21.7% to $49.4M for full year 2025
- GAAP net income rose to $19.5M from $7.7M in 2024 (full year)
- Q4 adjusted EBITDA +16% to $11.9M versus prior-year quarter
- Digital new customers +98% in Q4, driving Digital sales +47% in Q4
- Repurchased 1,260,000 shares for $16.3M; company ended 2025 with $93.9M cash and no debt
- Net cash provided by operations $35.3M in 2025 (vs $25.3M in 2024)
Negative
- Fourth-quarter SG&A increased 10.8% to $48.4M and rose to 39.1% of net sales
News Market Reaction – NATR
In the Mar 11 session, NATR declined 1.28%, reflecting a mild negative market reaction. Argus tracked a peak move of +4.7% during that session. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 06 | Quarterly earnings | Positive | +30.5% | Q3 2025 sales, EPS and adjusted EBITDA all grew strongly year over year. |
| Jul 31 | Quarterly earnings | Positive | +12.8% | Q2 2025 delivered higher sales, GAAP net income and adjusted EBITDA versus 2024. |
| May 06 | Quarterly earnings | Positive | +6.8% | Q1 2025 showed sales, net income and adjusted EBITDA growth with strong Asia, Europe. |
| Mar 11 | Annual earnings | Negative | -6.8% | Q4 2024 net loss and lower full‑year GAAP income despite higher sales and EBITDA. |
| Nov 07 | Quarterly earnings | Positive | +7.5% | Q3 2024 posted higher sales, GAAP net income and adjusted EBITDA vs prior year. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings releases have consistently driven positive price reactions, with all recent earnings events showing aligned positive moves and an average move of about 10%.
Over the past five earnings cycles, Nature’s Sunshine has repeatedly reported rising net sales, expanding adjusted EBITDA and, in several quarters, raised full‑year guidance. Q1–Q3 2025 each showed year‑over‑year growth and positive price reactions ranging from +6.77% to +30.52%. Even when Q4 2024 included a small GAAP net loss, the company still delivered higher sales and adjusted EBITDA. Today’s Q4 and full‑year 2025 results extend this pattern of growth and improving profitability.
Key Terms
gaap financial
adjusted ebitda financial
non-gaap financial
sg&a financial
operating income financial
net cash provided by operating activities financial
volume incentives financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter 2025 Financial Summary vs. Same Year-Ago Quarter
- Net sales were up
4.7% to$123.8 million compared to$118.2 million (up3.8% in constant currency). - GAAP net income attributable to common shareholders of
$4.1 million , or$0.23 per diluted share, compared to net loss of$0.3 million , or$(0.02) per diluted share. - Adjusted EBITDA up
16% to$11.9 million compared to$10.3 million .
Full Year 2025 Financial Summary vs. 2024
- Net sales were up
5.7% to$480.1 million compared to$454.4 million (up5.3% in constant currency). - GAAP net income attributable to common shareholders of
$19.5 million , or$1.06 per diluted share, compared to$7.7 million , or$0.40 per diluted share. - Adjusted EBITDA up
21.7% to$49.4 million compared to$40.5 million .
Management Commentary
“We finished a record year in sales and delivered our second‑best quarter ever and our largest Q4 on record, with sales and adjusted EBITDA up
“We continue to see strong momentum in our Digital strategy, supported by exceptional customer acquisition. In Q4, new customers in our Digital channels grew
“After my first quarter at Nature’s Sunshine, I am even more delighted with the potential of our company. As we look ahead, we are in the early stages of laying the groundwork to accelerate growth across the business driven by continued acceleration into digital channels, driving deeper penetration in our existing markets, expanding into new geographies, introducing more innovative products and unlocking new channels.”
Fourth Quarter 2025 Financial Results
| Net Sales by Operating Segment (Amounts in Thousands) | ||||||||||||||
| Three Months Ended December 31, 2025 | Three Months Ended December 31, 2024 | Percent Change | Impact of Currency Exchange | Percent Change Excluding Impact of Currency | ||||||||||
| Asia | $ | 55,735 | $ | 56,297 | (1.0)% | $ | 146 | (1.3)% | ||||||
| Europe | 25,171 | 21,324 | 18.0 | 761 | 14.5 | |||||||||
| North America | 37,392 | 35,130 | 6.4 | 3 | 6.4 | |||||||||
| Latin America and Other | 5,509 | 5,454 | 1.0 | 146 | (1.7 | ) | ||||||||
| $ | 123,807 | $ | 118,205 | 4.7 | % | $ | 1,056 | 3.8 | % | |||||
Net sales in the fourth quarter of 2025 increased
Gross margin in the fourth quarter increased to
Volume incentives as a percentage of net sales decreased to
Selling, general and administrative expenses (“SG&A”) in the fourth quarter were
Operating income in the fourth quarter was
Other income (loss), net, in the fourth quarter of 2025 was
GAAP net income (loss) attributable to common shareholders was net income of
Non-GAAP net income attributable to common shareholders was
Adjusted EBITDA in the fourth quarter increased
Full Year 2025 Financial Results
| Net Sales by Operating Segment (Amounts in Thousands) | |||||||||||||||
| Year Ended December 31, 2025 | Year Ended December 31, 2024 | Percent Change | Impact of Currency Exchange | Percent Change Excluding Impact of Currency | |||||||||||
| Asia | $ | 221,777 | $ | 207,794 | 6.7 | % | $ | 668 | 6.4 | % | |||||
| Europe | 93,133 | 84,837 | 9.8 | 1,682 | 7.8 | ||||||||||
| North America | 143,611 | 138,849 | 3.4 | (210 | ) | 3.6 | |||||||||
| Latin America and Other | 21,623 | 22,884 | (5.5 | ) | (295 | ) | (4.2 | ) | |||||||
| $ | 480,144 | $ | 454,364 | 5.7 | % | $ | 1,845 | 5.3 | % | ||||||
Net sales in 2025 increased
Gross margin in 2025 increased to
Volume incentives as a percentage of net sales in 2025 were
SG&A in 2025 were
Operating income in 2025 was
Other income (loss), net, in 2025 was income of
GAAP net income attributable to common shareholders was
Non-GAAP net income attributable to common shareholders in 2025 was
Adjusted EBITDA in 2025 increased
Balance Sheet and Cash Flow
Net cash provided by operating activities was
Outlook
The Company expects full year 2026 net sales to range between
Conference Call
The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its fourth quarter and full year 2025 results.
Date: Tuesday, March 10th, 2026
Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)
Toll-free dial-in number: 1-800-717-1738
International dial-in number: 1-646-307-1865
Conference ID: 08247
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.
The conference call will be broadcast live and available for replay here and via the Events section of the Nature’s Sunshine website here.
A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through Tuesday, March 24, 2026.
Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 1108247
About Nature’s Sunshine Products
Nature’s Sunshine Products (Nasdaq: NATR), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, distributes its products in more than 40 countries worldwide. Additional information about the Company can be obtained at its website, www.naturessunshine.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements regarding the Company’s future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to the Company’s objectives, plans, strategies and financial results, including outlook for 2026 net sales and adjusted EBITDA. All statements (other than statements of historical fact) that address activities, events or developments that the Company intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, including the following:
- failure to comply with laws and regulations relating to trade restrictions and export controls;
- laws and regulations regarding direct selling that may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets;
- current and potential future extensive government regulations to which the Company’s products, business practices and manufacturing activities are subject;
- registration of products for sale in foreign markets, or difficulty or increased cost of importing products into foreign markets;
- legal challenges to the Company’s direct selling program or to the classification of its independent consultants;
- failure of the Company’s independent consultants to comply with advertising laws;
- product liability claims;
- impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;
- the Company’s ability to attract and retain independent consultants;
- the loss of one or more key independent consultants who have a significant sales network;
- potential for liability relating to the Company’s full ownership of China business;
- the effect of fluctuating foreign exchange rates;
- liabilities and obligations arising from improper activity by the Company’s independent consultants;
- changes to the Company’s independent consultant compensation plans;
- geopolitical issues, conflicts or other global events;
- negative consequences resulting from difficult economic conditions, including the availability of liquidity or the willingness of the Company’s customers to purchase products;
- risks associated with the manufacturing of the Company’s products;
- supply chain disruptions, manufacturing interruptions or delays or the failure to accurately forecast customer demand;
- failure to timely and effectively obtain shipments of products from our suppliers and deliver products to our independent consultants and customers;
- uncertainties relating to the application of transfer pricing, duties, value-added taxes and other tax regulations, and changes thereto;
- failure to maintain an effective system of internal controls over financial reporting;
- cybersecurity threats and exposure to data loss;
- the storage, processing and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations;
- reliance on information technology infrastructure; and
- the sufficiency of trademarks and other intellectual property rights.
These and other risks and uncertainties that could cause actual results to differ from predicted results are more fully detailed under the caption “Risk Factors” in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports filed on Form 10-Q.
All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this press release. Except as is required by law, the Company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this press release.
Non-GAAP Financial Measures
We have included information which has not been prepared in accordance with generally accepted accounting principles (GAAP), such as information concerning non-GAAP net income, adjusted EBITDA and net sales excluding the impact of foreign currency exchange fluctuations.
We utilize the non-GAAP measures of non-GAAP net income and adjusted EBITDA in the evaluation of our operations and believe that these measures are useful indicators of our ability to fund our business. These non-GAAP financial measures should not be considered as an alternative to, or more meaningful than, U.S. GAAP net income (loss) as an indicator of our operating performance.
Other companies may use the same or similarly named measures, but exclude different items, which may not provide investors with a comparable view of Nature’s Sunshine Products’ performance in relation to other companies. We have included a reconciliation of net income to adjusted EBITDA, the most comparable GAAP measure. We have also included a reconciliation of GAAP net income to non-GAAP net income and non-GAAP adjusted EPS, in the attached financial tables.
Net sales in local currency removes, from net sales in U.S. dollars, the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries. This is accomplished by translating the current period net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period.
We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. Net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.
With respect to our Adjusted EBITDA outlook for the full year 2026, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, we are unable to assess the probable significance of the unavailable information, which could have a material impact on our future GAAP financial results.
Investor Relations:
Gateway Group, Inc.
Cody Slach
1-949-574-3860
NATR@gateway-grp.com
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Amounts in thousands, except per share information) (Unaudited) | |||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net sales | $ | 123,807 | $ | 118,205 | $ | 480,144 | $ | 454,364 | |||||||
| Cost of sales | (34,028 | ) | (33,141 | ) | (132,420 | ) | (129,676 | ) | |||||||
| Gross profit | 89,779 | 85,064 | 347,724 | 324,688 | |||||||||||
| Operating expenses: | |||||||||||||||
| Volume incentives | 36,039 | 36,805 | 144,591 | 140,589 | |||||||||||
| Selling, general and administrative | 48,418 | 43,709 | 178,390 | 164,004 | |||||||||||
| Operating income | 5,322 | 4,550 | 24,743 | 20,095 | |||||||||||
| Other income (loss), net | 165 | (3,101 | ) | 5,069 | (1,669 | ) | |||||||||
| Income before provision for income taxes | 5,487 | 1,449 | 29,812 | 18,426 | |||||||||||
| Provision for income taxes | 974 | 2,181 | 9,361 | 10,534 | |||||||||||
| Net income (loss) | 4,513 | (732 | ) | 20,451 | 7,892 | ||||||||||
| Net income (loss) attributable to noncontrolling interests | 406 | (411 | ) | 930 | 196 | ||||||||||
| Net income (loss) attributable to common shareholders | $ | 4,107 | $ | (321 | ) | $ | 19,521 | $ | 7,696 | ||||||
| Basic and diluted net income (loss) per common share: | |||||||||||||||
| Basic earnings (loss) per share attributable to common shareholders | $ | 0.23 | $ | (0.02 | ) | $ | 1.08 | $ | 0.41 | ||||||
| Diluted earnings (loss) per share attributable to common shareholders | $ | 0.23 | $ | (0.02 | ) | $ | 1.06 | $ | 0.40 | ||||||
| Weighted-average basic common shares outstanding | 17,501 | 18,479 | 18,005 | 18,616 | |||||||||||
| Weighted-average diluted common shares outstanding | 17,922 | 18,479 | 18,468 | 19,089 | |||||||||||
NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
(Unaudited)
| As of December 31, | 2025 | 2024 | |||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 93,891 | $ | 84,700 | |||
| Accounts receivable, net of allowance for doubtful accounts of | 8,602 | 9,477 | |||||
| Inventories | 68,312 | 59,443 | |||||
| Prepaid expenses and other | 8,040 | 6,959 | |||||
| Total current assets | 178,845 | 160,579 | |||||
| Property, plant and equipment, net | 32,915 | 39,585 | |||||
| Operating lease right-of-use assets | 17,600 | 12,799 | |||||
| Restricted investment securities - trading | 1,132 | 915 | |||||
| Deferred income tax assets | 20,068 | 17,644 | |||||
| Other assets | 10,586 | 9,333 | |||||
| Total assets | $ | 261,146 | $ | 240,855 | |||
| Liabilities and Shareholders’ Equity | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 8,021 | $ | 8,912 | |||
| Accrued volume incentives and service fees | 22,624 | 20,563 | |||||
| Accrued liabilities | 34,080 | 25,399 | |||||
| Deferred revenue | 5,840 | 2,774 | |||||
| Income taxes payable | 4,703 | 4,117 | |||||
| Current portion of operating lease liabilities | 3,270 | 3,927 | |||||
| Total current liabilities | 78,538 | 65,692 | |||||
| Liability related to unrecognized tax benefits | 428 | 628 | |||||
| Long-term portion of operating lease liabilities | 15,630 | 10,277 | |||||
| Deferred compensation payable | 1,132 | 915 | |||||
| Deferred income tax liabilities | 954 | 1,007 | |||||
| Other liabilities | 2,911 | 1,345 | |||||
| Total liabilities | 99,593 | 79,864 | |||||
| Shareholders’ equity: | |||||||
| Common stock, no par value; 50,000 shares authorized, 17,508 and 18,483 shares issued and outstanding as of December 31, 2025, and 2024, respectively | 102,192 | 114,577 | |||||
| Retained earnings | 76,928 | 57,407 | |||||
| Noncontrolling interest | — | 5,678 | |||||
| Accumulated other comprehensive loss | (17,567 | ) | (16,671 | ) | |||
| Total shareholders’ equity | 161,553 | 160,991 | |||||
| Total liabilities and shareholders’ equity | $ | 261,146 | $ | 240,855 | |||
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in thousands) (Unaudited) | |||||||
| Year Ended December 31, | 2025 | 2024 | |||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net income | $ | 20,451 | $ | 7,892 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Depreciation and amortization | 13,844 | 14,219 | |||||
| Noncash lease expense | 4,952 | 5,420 | |||||
| Share-based compensation expense | 5,780 | 4,788 | |||||
| Loss on disposal or sale of property and equipment | 397 | 1,570 | |||||
| Deferred income taxes | (2,273 | ) | (1,662 | ) | |||
| Purchase of trading investment securities | (109 | ) | (141 | ) | |||
| Proceeds from sale of trading investment securities | 16 | 97 | |||||
| Realized and unrealized gains on investments | (125 | ) | (124 | ) | |||
| Foreign exchange (gains) losses | (4,522 | ) | 1,700 | ||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | 1,015 | (1,121 | ) | ||||
| Inventories | (7,824 | ) | 5,562 | ||||
| Prepaid expenses and other | (3,095 | ) | 528 | ||||
| Other assets | 844 | (560 | ) | ||||
| Accounts payable | (1,797 | ) | 1,085 | ||||
| Accrued volume incentives and service fees | 1,500 | (1,565 | ) | ||||
| Accrued liabilities | 8,502 | (5,512 | ) | ||||
| Deferred revenue | 2,868 | 1,041 | |||||
| Lease liabilities | (5,061 | ) | (5,568 | ) | |||
| Income taxes payable | (60 | ) | (2,938 | ) | |||
| Liability related to unrecognized tax positions | (200 | ) | 419 | ||||
| Deferred compensation payable | 218 | 168 | |||||
| Net cash provided by operating activities | 35,321 | 25,298 | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Purchases of property, plant and equipment | (6,480 | ) | (10,971 | ) | |||
| Net cash used in investing activities | (6,480 | ) | (10,971 | ) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Proceeds from revolving credit facility | 5,087 | 40,991 | |||||
| Principal payments of revolving credit facility | (5,087 | ) | (40,991 | ) | |||
| Acquisition of nocontrolling interest | (6,162 | ) | — | ||||
| Payments related to tax withholding for net-share settled equity awards | (1,302 | ) | (1,046 | ) | |||
| Repurchase of common stock | (16,309 | ) | (8,859 | ) | |||
| Net cash used in financing activities | (23,773 | ) | (9,905 | ) | |||
| Effect of exchange rates on cash and cash equivalents | 4,123 | (2,095 | ) | ||||
| Net increase in cash and cash equivalents | 9,191 | 2,327 | |||||
| Cash and cash equivalents at beginning of the year | 84,700 | 82,373 | |||||
| Cash and cash equivalents at end of the year | $ | 93,891 | $ | 84,700 | |||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |||||||
| Cash paid for income taxes, net of refunds | $ | 12,547 | $ | 14,788 | |||
| Cash paid for interest | 98 | 119 | |||||
NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(Amounts in thousands)
(Unaudited)
| Three Months Ended December 31, | Year Ended December 31, | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| Net income (loss) | $ | 4,513 | $ | (732 | ) | $ | 20,451 | $ | 7,892 | |||||
| Adjustments: | ||||||||||||||
| Depreciation and amortization | 3,306 | 4,024 | 13,844 | 14,219 | ||||||||||
| Share-based compensation expense | 1,557 | 1,208 | 5,780 | 4,788 | ||||||||||
| Other (income) loss, net* | (165 | ) | 3,101 | (5,069 | ) | 1,669 | ||||||||
| Provision for income taxes | 974 | 2,181 | 9,361 | 10,534 | ||||||||||
| Other adjustments (1) | 1,746 | 485 | 4,985 | 1,442 | ||||||||||
| Adjusted EBITDA | $ | 11,931 | $ | 10,267 | $ | 49,352 | $ | 40,544 | ||||||
| (1) Other adjustments | ||||||||||||||
| Other non-recurring expenses | $ | 1,746 | $ | 485 | $ | 4,985 | $ | 1,442 | ||||||
| Total adjustments | $ | 1,746 | $ | 485 | $ | 4,985 | $ | 1,442 | ||||||
* Other (income) loss, net is primarily comprised of foreign exchange (gains) losses, interest income, and interest expense.
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES RECONCILIATION OF GAAP NET INCOME (LOSS) TO NON-GAAP NET INCOME (LOSS) and NON-GAAP ADJUSTED EPS (Amounts in thousands) (Unaudited) | |||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net income (loss) | $ | 4,513 | $ | (732 | ) | $ | 20,451 | $ | 7,892 | ||||||
| Adjustments: | |||||||||||||||
| Loss on disposal of property and equipment | — | — | — | — | |||||||||||
| Restructuring and other related expenses | — | — | — | — | |||||||||||
| Other non-recurring expenses | 1,746 | 485 | 4,985 | 1,442 | |||||||||||
| VAT refund | — | — | — | — | |||||||||||
| Tax impact of adjustments | (436 | ) | (121 | ) | (1,246 | ) | (276 | ) | |||||||
| Total adjustments | 1,310 | 364 | 3,739 | 1,166 | |||||||||||
| Non-GAAP net income (loss) | $ | 5,823 | $ | (368 | ) | $ | 24,190 | $ | 9,058 | ||||||
| Reported net income (loss) attributable to common shareholders | $ | 4,107 | $ | (321 | ) | $ | 19,521 | $ | 7,696 | ||||||
| Total adjustments | 1,310 | 364 | 3,739 | 1,166 | |||||||||||
| Non-GAAP net income attributable to common shareholders | $ | 5,417 | $ | 43 | $ | 23,260 | $ | 8,862 | |||||||
| Basic income (loss) per share, as reported | $ | 0.23 | $ | (0.02 | ) | $ | 1.08 | $ | 0.41 | ||||||
| Total adjustments, net of tax | 0.07 | 0.02 | 0.21 | 0.06 | |||||||||||
| Basic income per share, as adjusted | $ | 0.30 | $ | — | $ | 1.29 | $ | 0.47 | |||||||
| Diluted income (loss) per share, as reported | $ | 0.23 | $ | (0.02 | ) | $ | 1.06 | $ | 0.40 | ||||||
| Total adjustments, net of tax | 0.07 | 0.02 | 0.20 | 0.06 | |||||||||||
| Diluted income per share, as adjusted | $ | 0.30 | $ | — | $ | 1.26 | $ | 0.46 | |||||||
